Search filters

List of works by Hayato Hikita

Clinical outcomes of direct-acting antiviral treatments for hepatitis C patients after hepatocellular carcinoma are equivalent to interferon treatment

scientific article published on 17 July 2020

Cotreatment with lenvatinib and warfarin potassium caused prothrombin time prolongation

scientific article published on 10 July 2019

Forkhead Box M1 Transcription Factor Drives Liver Inflammation Linking to Hepatocarcinogenesis in Mice

scientific article published on 24 October 2019

Frequency of, and factors associated with, hepatitis B virus reactivation in hepatitis C patients treated with all-oral direct-acting antivirals: Analysis of a Japanese prospective cohort.

scientific article published on 5 June 2017

Hepatocellular Carcinoma Due to a Baffle Obstruction After the Mustard Operation: A Case Report

scientific article published on 22 December 2017

Hepatocellular carcinoma occurrence does not differ between interferon-based and interferon-free treatment with liver histological assessment

scientific article published on 08 January 2020

Hypovascular hepatic nodules as a predictive factor for transcatheter arterial chemoembolization refractoriness in hepatocellular carcinoma

scientific article published on 01 December 2019

Incidence and risk factors of hepatocellular carcinoma change over time in patients with hepatitis C virus infection who achieved sustained virologic response

scientific article published on 06 February 2019

Increased FoxM1 expression is associated with clinicopathological features and confers a poor prognosis in human hepatocellular carcinoma.

scientific article published on 21 December 2016

Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice

scientific article published on 11 July 2011

Initial treatment response to transarterial chemoembolization as a predictive factor for Child-Pugh class deterioration prior to refractoriness in hepatocellular carcinoma

scientific article published on 18 August 2020

Liver Fibrosis Is Associated With Corrected QT Prolongation During Ledipasvir/Sofosbuvir Treatment for Patients With Chronic Hepatitis C

scientific article published on 06 August 2018

NS5A-P32 deletion after failure of ledipasvir/sofosbuvir in hepatitis C virus genotype 1b infection.

scientific article published on 9 February 2018

Predictive factors of anemia during sofosbuvir and ribavirin therapy for genotype 2 chronic hepatitis C patients

scientific article published on 23 May 2019

Risk of hepatocellular carcinoma after sustained virologic response in hepatitis C virus patients without advanced liver fibrosis

scientific article published on 24 June 2022

Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice.

scientific article published on 16 September 2016

Salvage cystic duct anastomosis using a magnetic compression technique for incomplete bile duct reconstruction in living donor liver transplantation

scientific article published on 01 January 2010

Signal transducer and activator of transcription 5 plays a crucial role in hepatic lipid metabolism through regulation of CD36 expression.

scientific article

Targeting the mevalonate pathway is a novel therapeutic approach to inhibit oncogenic FoxM1 transcription factor in human hepatocellular carcinoma.

scientific article

The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma

scientific article

Therapeutic efficacy of lenvatinib in hepatocellular carcinoma patients with portal hypertension

scientific article published on 19 June 2020

Ultra-deep sequencing analysis of resistance-associated variants during retreatment with simeprevir-based triple therapy after failure of telaprevir-based triple therapy in patients with genotype 1 hepatitis C virus infection.

scientific article